User profiles for "author:L de la Fuente"

Luisa de la Fuente

Universidad de Cantabria
Verified email at unican.es
Cited by 1670

Technology insight: the evolution of tissue-engineered vascular grafts—from research to clinical practice

…, A Marini, S Garrido, L De La Fuente… - Nature clinical practice …, 2007 - nature.com
There is a considerable clinical need for alternatives to the autologous vein and artery
tissues used for vascular reconstructive surgeries such as CABG, lower limb bypass …

Role of 2, 4-diacetylphloroglucinol-producing fluorescent Pseudomonas spp. in the defense of plant roots

…, OV Mavrodi, KL Schroeder, L De La Fuente… - Plant …, 2006 - thieme-connect.com
Plants have evolved strategies of stimulating and supporting specific groups of antagonistic
microorganisms in the rhizosphere as a defense against diseases caused by soilborne plant …

Cocaine use and risk of stroke: a systematic review

…, G Barrio, L Degenhardt, L De La Fuente… - Drug and alcohol …, 2014 - Elsevier
Background Both cocaine use and strokes impact public health. Cocaine is a putative cause
of strokes, but no systematic review of the scientific evidence has been published. Methods …

Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery

G Konig, TN McAllister, N Dusserre, SA Garrido… - Biomaterials, 2009 - Elsevier
We have previously reported the initial clinical feasibility with our small diameter tissue
engineered blood vessel (TEBV). Here we present in vitro results of the mechanical …

Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study

TN McAllister, M Maruszewski, SA Garrido… - The Lancet, 2009 - thelancet.com
Background Application of a tissue-engineered vascular graft for small-diameter vascular
reconstruction has been a long awaited and much anticipated advance for vascular surgery …

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

…, ME Fernández, MJ Peñarrubia, L de la Fuente… - Circulation …, 2004 - Am Heart Assoc
Bone marrow mononuclear cells (BMCs) from 20 patients with extensive reperfused
myocardial infarction (MI) were used to assess their myocardial regenerative capability “in …

Tissue-engineered blood vessel for adult arterial revascularization

N L'Heureux, TN McAllister… - New England Journal of …, 2007 - Mass Medical Soc
Tissue-Engineered Blood Vessel for Adult Arterial Revascularization Page 1 correspondence
n engl j med 357;14 www.nejm.org october 4, 2007 1451 were given to our patient; one was …

SQANTI: extensive characterization of long-read transcript sequences for quality control in full-length transcriptome identification and quantification

M Tardaguila, L De La Fuente, C Marti… - Genome …, 2018 - genome.cshlp.org
High-throughput sequencing of full-length transcripts using long reads has paved the way
for the discovery of thousands of novel transcripts, even in well-annotated mammalian …

Population reference values of the Spanish version of the Health Questionnaire SF-36

…, G Barrio, L Prieto, C Rodríguez, L De la Fuente - Medicina …, 1998 - europepmc.org
Background Perceived health status measurements reference values an important
information source for health services research. Population-based norms have been …

Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence

J Castilla, P Sobrino, L De La Fuente, I Noguer… - Aids, 2002 - journals.lww.com
Objective: To assess the repercussion of late diagnosis of HIV infection on AIDS incidence in
the era of highly active antiretroviral therapy. Design: Analysis of AIDS surveillance data …